Oncology
 |
|
20 december 2018 09:00:02 |
| New high-risk molecular subtypes of DLBCL identified (Nature Clinical Practice Oncology) |
|
Tweet |
| 86 viewsCategory: Oncology |
 Physician burnout: let`s avoid unsubstantiated claims (Nature Clinical Practice Oncology)PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study (British Journal of Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
